Oddo BHF Asset Management Sas Boosts Holdings in Mettler-Toledo International, Inc. $MTD

Oddo BHF Asset Management Sas raised its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 56.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,572 shares of the medical instruments supplier’s stock after purchasing an additional 1,283 shares during the period. Oddo BHF Asset Management Sas’ holdings in Mettler-Toledo International were worth $4,980,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC lifted its holdings in Mettler-Toledo International by 2.4% during the third quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock valued at $361,000 after purchasing an additional 7 shares in the last quarter. Allworth Financial LP lifted its stake in shares of Mettler-Toledo International by 6.1% in the third quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock worth $149,000 after buying an additional 7 shares in the last quarter. Evergreen Capital Management LLC lifted its stake in shares of Mettler-Toledo International by 4.5% in the fourth quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock worth $257,000 after buying an additional 8 shares in the last quarter. Meridian Wealth Management LLC lifted its stake in shares of Mettler-Toledo International by 1.7% in the fourth quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock worth $680,000 after buying an additional 8 shares in the last quarter. Finally, Verdence Capital Advisors LLC lifted its stake in shares of Mettler-Toledo International by 2.0% in the fourth quarter. Verdence Capital Advisors LLC now owns 458 shares of the medical instruments supplier’s stock worth $639,000 after buying an additional 9 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Barclays decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and raised their price target for the stock from $1,400.00 to $1,450.00 in a research note on Friday, March 20th. Morgan Stanley cut their price objective on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $1,408.55.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,154.42 on Tuesday. Mettler-Toledo International, Inc. has a 1-year low of $1,023.05 and a 1-year high of $1,525.17. The stock has a market cap of $23.33 billion, a PE ratio of 27.07, a P/E/G ratio of 2.36 and a beta of 1.27. The firm has a 50-day simple moving average of $1,201.73 and a two-hundred day simple moving average of $1,310.13.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business had revenue of $947.13 million during the quarter, compared to analysts’ expectations of $943.14 million. During the same period last year, the business earned $8.19 earnings per share. The business’s revenue for the quarter was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, sell-side analysts expect that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.